Segment Information (Q2) - Segment Information (Details) - Reportable Segment - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Segment Reporting [Line Items] | ||||||
| Collaboration revenue | $ 21,000 | $ 0 | $ 21,000 | $ 0 | $ 0 | $ 1,885 |
| General and administrative support | 6,678 | 3,486 | 11,250 | 7,309 | 12,428 | 14,330 |
| Clinical development | 3,047 | 5,710 | 6,690 | 10,039 | 19,187 | 16,361 |
| Research and discovery | 1,028 | 3,537 | 3,183 | 6,856 | 12,660 | 14,389 |
| Manufacturing | 218 | 2,610 | 1,792 | 6,698 | 8,523 | 19,759 |
| Other segment expenses | 2,871 | 2,199 | 4,198 | 4,631 | 7,879 | 10,640 |
| Interest income | 277 | 850 | 710 | 1,847 | 3,108 | 6,673 |
| Interest expense | (475) | (1,301) | (1,843) | (2,564) | (5,274) | (4,656) |
| Loss on extinguishment of note payable | (3,354) | 0 | (3,354) | 0 | 0 | (553) |
| Other income, net | 64 | 11 | 738 | 179 | 2,021 | 1,615 |
| Net loss | $ 3,670 | $ (17,982) | $ (9,862) | $ (36,071) | $ (60,822) | $ (70,515) |
| X | ||||||||||
- Definition Operating Expense, Clinical Development, Adjustment No definition available.
|
| X | ||||||||||
- Definition Operating Expense, Manufacturing, Adjustment No definition available.
|
| X | ||||||||||
- Definition Operating Expense, Research and Discovery, Adjustment No definition available.
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|